#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3424931	Functional	Antiviral activity against Coxsackievirus B5 infected in African green monkey Vero 76 cells after 3 days by plaque reduction assay	Coxsackievirus B5	22	ALA3421576	organism-based format	Scientific Literature
2.	ALA3619373	Functional	Antiviral activity against Human coxsackievirus B5 ATCC VR-29 infected in African green monkey Vero 76 cells assessed as reduction of virus-plaque formation after 3 days by crystal violet staining	Coxsackievirus B5	32	ALA3616436	organism-based format	Scientific Literature
3.	ALA3738055	Functional	Antiviral activity against human CVB5 infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 3 days by plaque reduction assay	Coxsackievirus B5	73	ALA3734667	organism-based format	Scientific Literature
4.	ALA3738576	Functional	Ratio of NM108 EC50 to compound EC50 for human CVB5	Coxsackievirus B5	1	ALA3734667	organism-based format	Scientific Literature
5.	ALA3738577	Functional	Ratio of NM176 EC50 to compound EC50 for human CVB5	Coxsackievirus B5	1	ALA3734667	organism-based format	Scientific Literature
6.	ALA3738675	Functional	Antiviral activity against CVB-5 virus Faulkner ATCC VR-185 infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay	Coxsackievirus B5	31	ALA3734708	organism-based format	Scientific Literature
7.	ALA3782495	Functional	Antiviral activity against Human coxsackievirus B5 infected in african green monkey Vero cells after 24 to 36 hrs by MTS-based CPE reduction assay	Coxsackievirus B5	5	ALA3779764	organism-based format	Scientific Literature
8.	ALA666393	Functional	Inhibitory concentration required to reduce viral plaque formation of Coxsackie B5 virus by 50%	Coxsackievirus B5	3	ALA1132137	organism-based format	Scientific Literature
9.	ALA666394	Functional	Antiviral activity against the Coxsackie B5 virus (RNA virus) at a concentration of 2 ug/mL was determined as total cell infectious dose 50/mL (TCID50) by viral yield assay	Coxsackievirus B5	3	ALA1132137	organism-based format	Scientific Literature
10.	ALA666395	Functional	Antiviral activity against the Coxsackie B5 virus (RNA virus) at a concentration of 3 ug/mL was determined as total cell infectious dose 50/mL (TCID50) by viral yield assay	Coxsackievirus B5	5	ALA1132137	organism-based format	Scientific Literature
11.	ALA664047	Functional	Antiviral activity against the Coxsackie B5 virus (RNA virus) at a concentration of 4 ug/mL was determined as total cell infectious dose 50/mL (TCID50) by viral yield assay	Coxsackievirus B5	1	ALA1132137	organism-based format	Scientific Literature
12.	ALA664048	Functional	Antiviral activity against the Coxsackie B5 virus (RNA virus) at a concentration of 5 ug/mL was determined as total cell infectious dose 50/mL (TCID50) by viral yield assay	Coxsackievirus B5	2	ALA1132137	organism-based format	Scientific Literature
13.	ALA664049	Functional	Antiviral activity against the Coxsackie B5 virus (RNA virus) at a concentration of 80 ug/mL was determined as total cell infectious dose 50/mL (TCID50) by viral yield assay	Coxsackievirus B5	1	ALA1132137	organism-based format	Scientific Literature
14.	ALA894793	Functional	Antiviral activity against Coxsackievirus B5 in GMK cells by MTT assay	Coxsackievirus B5	9	ALA1148692	organism-based format	Scientific Literature
15.	ALA3368955	Functional	Antiviral activity against Coxsackievirus B5 infected in african green monkey Vero 76 cells assessed as reduction in plaque number after 3 days by plaque reduction assay	Coxsackievirus B5	79	ALA3351523	organism-based format	Scientific Literature
16.	ALA3364348	Functional	Antiviral activity against Coxsackievirus B5 Faulkner (ATCC VR-185) infected in Vero 76 cells after 3 days by plaque reduction assays	Coxsackievirus B5	19	ALA3352401	organism-based format	Scientific Literature
17.	ALA1941433	Functional	Antiviral activity against Human coxsackievirus B5 Ohio-1 infected in african green monkey Vero 76 cells assessed as reduction of virus-induced plaque formation after 3 days using crystal violet staining	Coxsackievirus B5	44	ALA1938334	organism-based format	Scientific Literature
18.	ALA1653255	Functional	Antiviral activity against Coxsackievirus B5 infected in human RD cells assessed as protection against virus-induced cytopathogenicity	Coxsackievirus B5	1	ALA1649506	organism-based format	Scientific Literature
19.	ALA994937	Functional	Antiviral activity against Coxsackievirus B5 in african green monkey Vero cells	Coxsackievirus B5	6	ALA1158184	organism-based format	Scientific Literature
20.	ALA1659322	Functional	Antiviral activity against Coxsackievirus serotype B5 infected in african green monkey BGMK cells assessed as inhibition of virus induced cytopathic effect after 18 to 24 hrs	Coxsackievirus B5	1	ALA1649227	organism-based format	Scientific Literature